nirmatrelvir-ritonavir
Sponsors
University of Melbourne, Shandong Provincial Hospital, First People's Hospital of Hangzhou, Pfizer
Conditions
COVID-19COVID-19 (Coronavirus Disease 2019)Hospitalized PatientsSARS-CoV-2 Infection (COVID-19)
Phase 3
Phase 4
Unknown Phase
Appropriate Evaluation of Antiviral Therapy With Nirmatrelvir-ritonavir in Hospitalized Patients
NCT05749445
Start: 2022-12-15End: 2023-04-30Target: 200Updated: 2023-03-01
A US Study to Look at Loss of Work and Healthcare Costs for People Affected With Mild-to-moderate COVID 19 Who Have High Chances of the Disease Becoming Severe
CompletedNCT07072793
Start: 2024-10-31End: 2024-11-15Updated: 2026-02-09
A Study to Understand How the Use of Paxlovid Affected Healthcare Use in People With Pre-existing Conditions.
CompletedNCT07090486
Start: 2025-04-15End: 2025-04-15Updated: 2025-07-29
A Study to Learn How Paxlovid [Nirmatrelvir-ritonavir/PF-07321332] Works in COVID-19 Patients Who Are Elderly or Have Medical Conditions.
Active, not recruitingNCT07261085
Start: 2025-10-27End: 2026-03-30Updated: 2025-12-04